Veracyte develops AI-powered molecular diagnostic tests that help physicians make treatment decisions for patients with cancer and other diseases. The platform combines genomic analysis, machine learning, and clinical data to provide precise diagnostic information. Features include cancer classification algorithms, treatment response prediction, risk stratification models, and integration with clinical workflows. Veracyte tests cover thyroid, lung, breast, and other cancers, helping doctors avoid unnecessary procedures and select optimal treatments based on molecular signatures.
